ReShape Lifesciences Inc

Contributing Author

Recent Articles by ReShape Lifesciences Inc

Jul-01	ReShape Lifesciences Granted U.S. Patent Related to an Intragastric Balloon System RSLS GlobeNewswire
Jun-27	ReShape Lifesciences Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement RSLS GlobeNewswire
Jun-26	ReShape Lifesciences Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys RSLS GlobeNewswire
Jun-25	ReShape Lifesciences Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology RSLS GlobeNewswire
Jun-12	ReShape Lifesciences Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets RSLS GlobeNewswire
Jun-09	ReShape Lifesciences Announces Pricing of $2.6 Million Public Offering RSLS GlobeNewswire
Jun-03	ReShape Lifesciences Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio RSLS GlobeNewswire
May-21	ReShape Lifesciences Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update RSLS GlobeNewswire
May-07	ReShape Lifesciences Announces 1-for-25 Reverse Stock Split RSLS GlobeNewswire
May-02	ReShape Lifesciences Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium RSLS GlobeNewswire